Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human heparan N-sulfatase

EU orphan designation number: EU/3/08/582   
Active ingredient: Recombinant human heparan N-sulfatase
Indication: Treatment of mucopolysaccharidosis, type IIIA (Sanfilippo A syndrome)
Sponsor: Shire Pharmaceutical Development Limited
Hampshire International Business Park, Chineham, Basingstoke, Hampshire RG24 8EP, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/11/2008 Centralised Orphan - Designation EMEA/OD/052/08 (2008)6857 of 07/11/2008